Position in WAT
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$7,210,885
+$6,937,813 QoQ
Shares Held
19,227
+1996.7% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#232
of 1,173 holders
Holding Since
Jun 2023
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in WAT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026AE Wealth Management LLC holds $24,387,586 across 14 Diagnostics & Research names. WAT ranks #1 (29.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WAT |
Waters Corp /De/
This page
|
19,227 | $7,210,885 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
5,903 | $3,107,559 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
4,866 | $2,439,600 | |
| 4 | RVTY |
Revvity, Inc.
|
17,248 | $1,918,992 | |
| 5 | DHR |
Danaher Corp /De/
|
9,172 | $1,747,067 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
8,599 | $1,661,487 | |
| 7 | DGX |
Quest Diagnostics Inc
|
7,291 | $1,545,317 | |
| 8 | NTRA |
Natera, Inc.
|
5,597 | $1,519,303 |
All Filings in WAT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,210,885 | 19,227 | Shares | Other | 2026-08-03 | |
| 2026-03-31 | $273,072 | 917 | Shares | Other | 2026-05-13 | |
| 2024-12-31 | $216,647 | 584 | Shares | Other | 2025-02-13 | |
| 2023-12-31 | $237,045 | 720 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $262,418 | 957 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $251,880 | 945 | Shares | Sole | 2023-07-10 | |
| No filing history on record for this holder in this stock. | ||||||